ClinicalTrials.gg
RecruitingNCT07912307BDNF-SDUpdated Nov 3, 2026

Sex Differences in BDNF Study

An interventional study of VO2peak Test in Exercise, BDNF and Sex Differences, sponsored by McMaster University. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by McMaster University · Not applicable, Interventional, and Basic science

Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
All
01

Study summary

A single bout of exercise can improve cognitive abilities like memory and attention. These functions help us navigate through everyday life. However, we do not fully understand how exercise improves cognitive abilities. We believe that exercise improves the brain by increasing the amount of BDNF in the blood. BDNF is very important for learning and memory. However, we still do not know if BDNF responds differently to exercise between females and males.

The purpose of this work is to characterize potential sex-differences in the circulating BDNF response to acute exercise. We will test the hypothesis that males will have greater serum and plasma BDNF responses compared to females following a maximal exercise test.

02

Conditions studied

  • Exercise
  • BDNF
  • Sex Differences

Browse trials for

Keywords

  • BDNF
  • sex differences
  • exercise
  • vo2peak
03

In context

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

This study's planned enrollment of 50 is below the median of 60 across 8,388 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

McMaster University is the lead sponsor of 741 studies on the registry; 127 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 3 (43%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 18 and 35

Exclusion criteria

Exclusion Criteria:

  • presence of type 2 diabetes
  • history of hypoglycaemia
  • history of concussion(s) with persistent symptoms
  • presence of major depressive disorder
  • history of cardiovascular events requiring hospitalization (i.e., heart attack, stroke)
  • presence of respiratory disease (e.g. asthma)
  • pre-existing injuries that prevent aerobic exercise participation.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    VO2peak Test

    Responses will be compared between males and females following a single experimental visit. Participants will complete a incremental ramp test to volitional exhaustion on a cycle ergometer, with venous blood draws characterizing BDNF responses at baseline and during the recovery period up to 1-hour post-exercise.

    Behavioral: VO2peak Test

Interventions

  • BehavioralVO2peak Test

    Incremental ramp test to volitional exhaustion on a cycle ergometer.

06

What researchers measure

Primary outcomes

  1. Plasma and Serum BDNF

    Measured via ELISA analysis of venous samples obtained from a forearm vein

    Time frame: At baseline and 0, 15, 30, 45, and 60 minutes post-exercise.

Secondary outcomes

  1. Platelet Count

    Measured from venous samples obtained from a forearm vein

    Time frame: At baseline and 0, 15, 30, 45, and 60 minutes post-exercise.

  2. Blood lactate

    Measured from venous samples obtained from a forearm vein

    Time frame: At baseline and 0, 15, 30, 45, and 60 minutes post-exercise.

  3. Oxygen uptake

    Breath-by-breath analysis performed via metabolic cart

    Time frame: During incremental ramp test to volitional exhaustion

  4. Flow-mediated dilation (FMD)

    Measured via brachial artery ultrasound

    Time frame: At baseline and 15 and 60 minutes post-exercise.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The investigators will share individual patient data (de-identified) with researchers upon request

Supporting information: Study protocol, Statistical analysis plan

Time frame: Beginning 12 months and ending 36 months following article publication.

Access criteria: Anyone who wishes to access the data.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07912307
Responsible party
Sponsor
First posted
Nov 3, 2026
Start date
Nov 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Nov 3, 2026

Study contacts

Jeremy J Walsh, PhD
Contact
walshj18@mcmaster.ca
905-525-9140 ext. 23523
Jeremy J Walsh, PhD
principal investigator · McMaster University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion